nafamostat has been researched along with Abdominal Aortic Aneurysm in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, H | 1 |
| Hata, T | 1 |
| Uda, A | 1 |
| Maemura, K | 1 |
| Ohsawa, T | 1 |
| Tsubota, M | 1 |
| Endo, M | 1 |
| Kobayashi, K | 1 |
| Sato, H | 1 |
| Seki, M | 1 |
| Morishita, K | 1 |
| Inoue, S | 1 |
| Baba, T | 1 |
| Sakata, J | 1 |
| Kazui, T | 1 |
| Abe, T | 1 |
1 trial available for nafamostat and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Our distal aortic perfusion system in descending thoracic and thoracoabdominal aortic aneurysm repairs.
Topics: Analysis of Variance; Anticoagulants; Antithrombins; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Th | 1997 |
2 other studies available for nafamostat and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Abdominal; Benzamidines; Blood Platelets; Blood Transfusion; | 2015 |
[A successfully treated case of thoracoabdominal aortic aneurysm complicated with the coagulation disorder].
Topics: Aged; Anticoagulants; Antithrombins; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Benzamid | 1995 |